Immunologic Adjuvants for Modern Vaccine Formulations
- 1 May 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 754 (1) , 153-160
- https://doi.org/10.1111/j.1749-6632.1995.tb44448.x
Abstract
Click on the article title to read more.Keywords
This publication has 27 references indexed in Scilit:
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody responseVaccine, 1992
- Immunological adjuvants: Desirable properties and side-effectsMolecular Immunology, 1991
- Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)Vaccine, 1991
- Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomesVaccine, 1990
- Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsNature, 1990
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responsesCellular Immunology, 1989
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- STUDIES ON THE O ANTIGEN OF SALMONELLA TYPHOSAThe Journal of Experimental Medicine, 1956